GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan · Delayed Price · Currency is TWD 19.85
+1.45 (7.88%)
Oct 8, 2026, 1:30 PM CST
GeneReach Biotechnology Market Cap
GeneReach Biotechnology has a market cap or net worth of 1.13 billion as of October 9, 2026. It is the 32,987th most valuable company in the world and the 1,988th biggest in Taiwan. Its market cap has increased by 13.42% in one year.
Market Cap
1.13B
Enterprise Value
1.06B
Revenue
238.08M
Global Rank
Country Rank
#1,988 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since November 19, 2012, GeneReach Biotechnology's market cap has decreased from 1.27B to 1.13B, a decrease of -11.31%. That is a compound annual growth rate of -0.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.13B | 4.04% |
| Dec 31, 2025 | 1.08B | -34.10% |
| Dec 31, 2024 | 1.65B | -27.38% |
| Dec 29, 2023 | 2.27B | -25.28% |
| Dec 30, 2022 | 3.03B | -20.04% |
| Dec 30, 2021 | 3.79B | -27.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abnova (Taiwan) | 1.37B |
| NeoCore Technology | 1.24B |
| Enimmune | 1.19B |
| Holy Stone Healthcare | 1.18B |
| Bio Preventive Medicine | 1.18B |
| LabTurbo Biotech | 1.11B |
| BiOptic | 1.03B |
| Level Biotechnology | 1.02B |